Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997.
Open Access
- 1 August 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 154 (8) , 797-803
- https://doi.org/10.1001/archpedi.154.8.797
Abstract
To compare the economic costs and benefits associated with using either diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) or diphtheria and tetanus toxoids and whole-cell pertussis vaccine (DTwP) in the United States in 1997.Keywords
This publication has 10 references indexed in Scilit:
- Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996Clinical Infectious Diseases, 1999
- Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994.The Journal of Infectious Diseases, 1997
- A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against PertussisNew England Journal of Medicine, 1996
- Epidemiological Features of Pertussis in the United States, 1980-1989Clinical Infectious Diseases, 1992
- Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reportingPublished by American Medical Association (AMA) ,1992
- Persistence of pertussis in an immunized population: Results of the Nova Scotia Enhanced Pertussis Surveillance ProgramThe Journal of Pediatrics, 1989
- Pertussis in Sweden after the cessation of general immunization in 1979The Pediatric Infectious Disease Journal, 1987
- Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costsJAMA, 1984
- Pertussis Vaccine — An Analysis of Benefits, Risks and CostsNew England Journal of Medicine, 1979
- Severity of notified whooping cough.BMJ, 1976